Home > Research > Browse

Research

Results for GLP-1/GIP dual agonist

Publications & Outputs

  1. The Novel DA-CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APPSWE/PS1ΔE9 Mouse Model

    Panagaki, T., Gengler, S. & Hölscher, C., 16/10/2018, In: Journal of Alzheimer's Disease. 66, 1, p. 195-218 24 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  2. DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease

    Cao, Y., Hölscher, C., Hu, M.-M., Wang, T., Zhao, F., Bai, Y., Zhang, J., Wu, M.-N. & Qi, J.-S., 15/05/2018, In: European Journal of Pharmacology. 827, p. 215-226 12 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review